Conditional overexpression of the wild-type Gsα as the gsp oncogene initiates chronic extracellularly regulated kinase 1/2 activation and hormone hypersecretion in pituitary cell lines

Endocrinology

Volumn 148, Issue 6, 2007, Pages 2973-2983

  Romano, D ^a   Magalon, K ^a   Pertuit, M ^a   Rasolonjanahary, R ^a   Barlier, A ^a   Enjalbert, A ^a   Gerard, C ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; DOXYCYCLINE; GROWTH HORMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH HORMONE SECRETING ADENOMA; HYPOPHYSIS CELL; NONHUMAN; ONCOGENE; ONCOGENE GSP; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTIN SYNTHESIS; RAT; WILD TYPE;

ADENYLATE CYCLASE; ANIMALS; CELL LINE; CYCLIC AMP; DOXYCYCLINE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROWTH HORMONE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; ONCOGENE PROTEINS; PROLACTIN; RATS; SOMATOTROPHS; TIME FACTORS; TRANSFECTION; TRANSGENES;

EID: 34250840807     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1273     Document Type: Article

References (55)

1. Stork PJ, Schmitt JM 2002 Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266
2. Dumaz N, Marais R 2005 Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J 272:3491-3504
3. Lin C, Lin SC, Chang CP, Rosenfeld MG 1992 Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 360:765-768
4. Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L 1995 Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Endocrinology 136:2088-2098
5. Ruvkun G 1992 Cell signalling. A molecular growth industry. Nature 360:711-712
6. Gourdji D, Bataille D, Vauclin N, Grouselle D, Rosselin G, Tixier-Vidal A 1979 Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release. FEBS Lett 104:165-168
7. Castillo AI, Tolon RM, Aranda A 1998 Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism. Oncogene 16:1981-1991
8. Kato Y, Iwasaki Y, Iwasaki J, Abe H, Yanaihara N, Imura H 1978 Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology 103:554-558
9. Le Pechon-Vallee C, Magalon K, Rasolonjanahary R, Enjalbert A, Gerard C 2000 Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3′-,5′-cyclic adenosine monophosphate pathway. Neuroendocrinology 72:46-56
10. Kievit P, Lauten JD, Maurer RA 2001 Analysis of the role of the mitogen-activated protein kinase in mediating cyclic-adenosine 3′-,5′-monophosphate effects on prolactin promoter activity. Mol Endocrinol 15:614-624
11. Romano D, Magalon K, Ciampini A, Talet C, Enjalbert A, Gerard C 2003 Differential involvement of the Ras and Rap1 small GTPases in vasoactive intestinal and pituitary adenylyl cyclase activating polypeptides control of the prolactin gene. J Biol Chem 278:51386-51394
12. Hammer RE, Brinster RL, Rosenfeld MG, Evans RM, Mayo KE 1985 Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature 315:413-416
13. Billestrup N, Swanson LW, Vale W 1986 Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA 83:6854-6857
14. Spiegel AM 1996 Defects in G protein-coupled signal transduction in human disease. Annu Rev Physiol 58:143-170
15. Vallar L, Spada A, Giannattasio G 1987 Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330:566-568
16. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L 1989 GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692-696
17. Lania A, Mantovani G, Spada A 2001 G protein mutations in endocrine diseases. Eur J Endocrinol 145:543-559
18. Spada A, Vallar L, Faglia G 1992 G protein oncogenes in pituitary tumors. Trends Endocrinol Metab 3:355-360
19. sα protein in growth hormone-secreting tumors. J Clin Endocrinol Metab 83:4386-4390
20. sα is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas. J Clin Endocrinol Metab 83:1624-1628
21. sα mutations. J Clin Endocrinol Metab 86:3795-3800
22. sα mutations in somatotroph adenomas. J Clin Endocrinol Metab 83:1604-1610
23. Hamacher C, Brocker M, Adams EF, Lei T, Fahlbusch R, Buchfelder M, Derwahl M 1998 Overexpression of stimulatory G protein α-subunit is a hallmark of most human somatotrophic pituitary tumours and is associated with resistance to GH-releasing hormone. Pituitary 1:13-23
24. Levine MA, Downs Jr RW, Singer M, Marx SJ, Aurbach GD, Spiegel AM 1980 Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun 94:1319-1324
25. Hardt SE, Geng YJ, Montagne O, Asai K, Hong C, Yang GP, Bishop SP, Kim SJ, Vatner DE, Seidman CE, Seidman JG, Homcy CJ, Vatner SF 2002 Accelerated cardiomyopathy in mice with overexpression of cardiac G (s) α and a missense mutation in the α-myosin heavy chain. Circulation 105:614-620
26. Gaiddon C, Mercken L, Bancroft C, Loeffler JP 1995 Transcriptional effects in GH3 cells of Gs α mutants associated with human pituitary tumors: stimulation of adenosine 3-′,5′-monophosphate response element-binding protein-mediated transcription and of prolactin and growth hormone promoter activity via protein kinase A. Endocrinology 136:4331-4338
27. Sα-subunits stimulate Pit-1 promoter activity via a protein kinase A-mediated pathway acting through deoxyribonucleic acid binding sites both for Pit-1 and for adenosine 3′-,5′-monophosphate response element-binding protein. Endocrinology 137:1286-1291
28. Ham J, Ivan M, Wynford-Thomas D, Scanlon MF 1997 GH3 cells expressing constitutively active Gsα (Q227L) show enhanced hormone secretion and proliferation. Mol Cell Endocrinol 127:41-47
29. Gossen M, Bujard H 1992 Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551
30. Hoffmann A, Villalba M, Journot L, Spengler D 1997 A novel tetracycline-dependent expression vector with low basal expression and potent regulatory properties in various mammalian cell lines. Nucleic Acids Res 25:1078-1079
31. Grishina G, Berlot CH 1998 Mutations at the domain interface of GSα impair receptor-mediated activation by altering receptor and guanine nucleotide binding. J Biol Chem 273:15053-15060
32. Hale KK, Trollinger D, Rihanek M, Manthey CL 1999 Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages. J Immunol 162:4246-4252
33. Moreau C, Rasolonjanahary R, Audinot V, Kordon C, Enjalbert A 1994 Angiotensin II effects on second messengers involved in prolactin secretion are mediated by AT1 receptor in anterior pituitary cells. Mol Cell Neurosci 5:597-603
34. Niswender GD, Chen CL, Midgley Jr AR, Meites J, Ellis S 1969 Radioimmunoassay for rat prolactin. Proc Soc Exp Biol Med 130:793-797
35. Pellegrini I, Roche C, Quentien MH, Ferrand M, Gunz G, Thirion S, Bagnis C, Enjalbert A, Franc JL 2006 Involvement of the pituitary-specific transcription factor pit-1 in somatolactotrope cell growth and death: an approach using dominant-negative pit-1 mutants. Mol Endocrinol 20:3212-3227
36. Peers B, Nalda AM, Monget P, Voz ML, Belayew A, Martial JA 1992 Binding of a 100-kDa ubiquitous factor to the human prolactin promoter is required for its basal and hormone-regulated activity. Eur J Biochem 210:53-58
37. Cohen LE, Hashimoto Y, Zanger K, Wondisford F, Radovick S 1999 CREB-independent regulation by CBP is a novel mechanism of human growth hormone gene expression. J Clin Invest 104:1123-1130
38. sα mutations. J Clin Endocrinol Metab 75:918-923
39. Ooi GT, Tawadros N, Escalona RM 2004 Pituitary cell lines and their endocrine applications. Mol Cell Endocrinol 228:1-21
40. Lania A, Mantovani G, Spada A 2003 Genetics of pituitary tumors: focus on G-protein mutations. Exp Biol Med (Maywood) 228:1004-1017
41. Howe JR, Skryabin BV, Belcher SM, Zerillo CA, Schmauss C 1995 The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem 270:14168-14174
42. Mitsutake N, Knauf JA, Mitsutake S, Mesa Jr C, Zhang L, Fagin JA 2005 Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res 65:2465-2473
43. Levis MJ, Bourne HR 1992 Activation of the α subunit of Gs in intact cells alters its abundance, rate of degradation, and membrane avidity. J Cell Biol 119:1297-1307
44. sα enhances activation of the adenylyl cyclase signal transduction cascade. Mol Endocrinol 11:1053-1061
45. Ohmichi M, Sawada T, Kanda Y, Koike K, Hirota K, Miyake A, Saltiel AR 1994 Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation. J Biol Chem 269:3783-3788
46. Pickett CA, Gutierrez-Hartmann A 1994 Ras mediates Src but not epidermal growth factor-receptor tyrosine kinase signaling pathways in GH4 neuroendocrine cells. Proc Natl Acad Sci USA 91:8612-8616
47. Lania A, Filopanti M, Corbetta S, Losa M, Ballare E, Beck-Peccoz P, Spada A 2003 Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells. J Clin Endocrinol Metab 88:1692-1696
48. Wang Z, Dillon TJ, Pokala V, Mishra S, Labudda K, Hunter B, Stork PJ 2006 Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation. Mol Cell Biol 26:2130-2145
49. Ma YC, Huang J, Ali S, Lowry W, Huang XY 2000 Src tyrosine kinase is a novel direct effector of G proteins. Cell 102:635-646
50. Tian J, Chen J, Bancroft C 1994 Expression of constitutively active Gs α-subunits in GH3 pituitary cells stimulates prolactin promoter activity. J Biol Chem 269:33-36
51. sα gene. J Clin Endocrinol Metab 86:2111-2117
52. Bertherat J, Chanson P, Montminy M 1995 The cyclic adenosine 3′-,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol Endocrinol 9:777-783
53. Hamacher C, Studer H, Zbaeren J, Schatz H, Derwahl M 1995 Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenylate cyclase activity and growth of these tumors. J Clin Endocrinol Metab 80:1724-1732
54. i2α, and somatostatin receptor 2 in human somatotroph adenomas: involvement in octreotide sensitivity. J Clin Endocrinol Metab 84:2759-2765
55. Buchfelder M, Fahlbusch R, Merz T, Symowski H, Adams EF 1999 Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes. Pituitary 1:181-185